Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2025-12-26 @ 1:17 PM
Study NCT ID:
NCT01611259
Status:
COMPLETED
Last Update Posted:
2017-11-06
First Post:
2012-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue
Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AGMT_MALT2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None